No Data
Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Potentially Undervalued?
Integra LifeSciences Holdings Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Integra's (IART) Q2 Earnings and Revenues Top, Margins Down
Integra LifeSciences Analysts Cut Their Forecasts After Q2 Results
JMP Securities Maintains Market Outperform on Integra Lifesciences, Lowers Price Target to $35
Morgan Stanley Maintains Integra Lifesciences(IART.US) With Sell Rating, Cuts Target Price to $25
Money Mover OP : $美敦力 (MDT.US)$ $直觉外科公司 (ISRG.US)$